Immage Biotherapeutics Corp.
IMMG · OTC
8/31/2016 | 8/31/2015 | 9/30/2014 | 9/30/2013 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $9 | $0 | $0 | $0 |
| Gross Profit | -$9 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $62 | $0 | $0 | $0 |
| G&A Expenses | $154 | $0 | $0 | $0 |
| SG&A Expenses | $146 | $0 | $0 | $0 |
| Sales & Mktg Exp. | -$9 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $208 | $0 | $0 | $0 |
| Operating Income | -$216 | -$0 | -$19 | -$12 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $19 | $12 |
| Pre-Tax Income | -$216 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | -$216 | -$0 | -$19 | -$12 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.001 | -0.033 | -0.008 |
| % Growth | -150% | 98.2% | -312.5% | – |
| EPS Diluted | -0.002 | -0.001 | -0.033 | -0.009 |
| Weighted Avg Shares Out | 145,306 | 102 | 562 | 1,501 |
| Weighted Avg Shares Out Dil | 145,306 | 102 | 561 | 1,365 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $9 | $0 | $0 | $0 |
| EBITDA | -$208 | -$0 | -$19 | -$12 |
| % Margin | – | – | – | – |